Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 286
- Primary Endpoint
- Number of Participants Diagnosed With Rheumatoid Arthritis Also Found to Have Dry Eye Disease
Study Overview
Brief Summary
This study will evaluate the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis. No treatment is administered in this study.
Detailed Description
We investigated the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis by information sheets and direct recruitment of patients of potential study participants diagnosed with rheumatoid arthritis. Subjective assessment for dry eye disease was performed using Ocular Surface Disease Index (OSDI) questionnaire. The following objective tests of dry eye disease were employed: tear osmolarity (TO), tear break-up time (TBUT), corneal fluorescein staining score and conjunctival lissamine green staining scores using the National Eye Institute-recommended grading system, and Schirmer without anesthetic. The Dry Eye Severity Grading Scheme highlighted by the Dry Eye WorkShop was adapted to quantify dry eye disease severity level.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosed with rheumatoid arthritis
- •18 years old or older
- •Speaks and understands English and/or Spanish
Exclusion Criteria
- •Unable to provide consent
Outcomes
Primary Outcomes
Number of Participants Diagnosed With Rheumatoid Arthritis Also Found to Have Dry Eye Disease
Time Frame: 1 day
Secondary Outcomes
No secondary outcomes reported
Investigators
Jasmine Yumori
Associate Professor
Western University of Health Sciences